Literature DB >> 7832792

c-jun inhibited the alternative splicing of neuron-specific amyloid precursor protein, but stimulated the non-neuron type one in P19 EC cells.

A Odaka1, T Tsukahara, M Momoi, T Momoi.   

Abstract

Three alternative splicing products of amyloid precursor protein (APP), APP770, 751 and 695, were detected in mouse embryonal carcinoma (EC) P19 cells by reverse transcriptase RNA polymerase chain reaction (RT-PCR). Alternative splicing of APP pre-mRNA in P19EC cells was remarkably changed by c-jun transformation. The relative ratio of APP770 encoding exons 7 and 8, non-neuron type, was increased by c-jun transformation, while that of APP 695 not encoding exons 7 and 8, neuron-specific one, was decreased. These results suggested that skipping of exons 7 and 8 was specifically blocked in c-jun transformed cells. APP 695, which increases in P19 EC cells under the culture conditions that induce the neuronal differentiation, did not increase in C2C5 cells under the same conditions, suggesting that c-jun transformed cells were not in the neuronal cell lineage and lost the ability to differentiate into neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7832792     DOI: 10.1006/bbrc.1995.1117

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  The association of GPR85 with PSD-95-neuroligin complex and autism spectrum disorder: a molecular analysis.

Authors:  Eriko Fujita-Jimbo; Yuko Tanabe; Zhiling Yu; Karin Kojima; Masato Mori; Hong Li; Sadahiko Iwamoto; Takanori Yamagata; Mariko Y Momoi; Takashi Momoi
Journal:  Mol Autism       Date:  2015-03-13       Impact factor: 7.509

2.  Mutation in Parkinson disease-associated, G-protein-coupled receptor 37 (GPR37/PaelR) is related to autism spectrum disorder.

Authors:  Eriko Fujita-Jimbo; Zhi-Ling Yu; Hong Li; Takanori Yamagata; Masato Mori; Takashi Momoi; Mariko Y Momoi
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.